4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>4.</strong> <strong>Hrvatski</strong> <strong>kongres</strong> <strong>kliniËke</strong> <strong>citologije</strong> / 1. <strong>Hrvatski</strong> simpozij analitiËke <strong>citologije</strong> / 2. <strong>Hrvatski</strong> simpozij citotehnologije<br />
120<br />
Klinička citologija - Posteri<br />
POLYOMAVIRUS ASSOCIATED NEPHROPATHY AFTER SIMULTANEOUS KIDNEY AND<br />
PANCREAS TRANSPLANTATION. CASE REPORT.<br />
Gracin S1 , Knotek M1 , Sabljar Matovinovic M1 , Kardum Skelin I1 , Ljubanovic D2 , Vidas Z1 1 Clinical hospital Merkur, Zagreb, Croatia.<br />
2 Clinical hospital Dubrava, Zagreb, Croatia.<br />
In renal allograft recipient, immunosuppressive drug therapy is the major cause of immunocompromised<br />
status and opportunistic infections leading to transplanted organ<br />
failure.<br />
During the last decade, polyomavirus virus associated nephropathy (PVAN) has been the<br />
major cause of a serious complication allograft failure in these patients. The prevalence<br />
of PVAN has increased from 1% to 10 % leading to loss of transplanted organ in 30% to<br />
80% of cases. Viremia precedes PVAN, and in the absence of specific antiviral drugs,<br />
early detection of disease and modification/reduction of immunosuppressive regimen<br />
currently is the cornerstone of therapy.<br />
Although PVAN nephropathy is well documented, it has not been thoroughly investigated<br />
in nonrenal and/or multiple organ transplantation; such are simultaneous kidney and<br />
pancreas transplantation (SPKT). In these specific conditions the diagnosis and therapy<br />
of PVAN can be even more challenging problem.<br />
We report a 32 years old patient who presented with PVAN 6 month after SPKT due to<br />
diabetic nephropathy. He received induction immunosuppression which included IL-2<br />
antibody (daclizumab), steroids, mycophenolate mofetil and tacrolimus. Diagnosis was<br />
made on the basis of protocol cytologic study in urine, examining Decoy cell and confirmed<br />
by histological examination of renal biopsy which revealed viral inclusions on<br />
light microscopy as well as positive immunohistochemistry analysis. Patient was treated<br />
with reduced immunosuppressive regimen, both tacrolimus and mycophenolate mofetil<br />
with continuation of small dose of prednisone. At two years follow up, patient has preserved<br />
kidney and pancreas function with estimated glomerular filtration rate of 84 ml/<br />
min and no signs of PVAN on his 2 year protocol kidney biopsy.<br />
sonja.gracin@gmail.com